SMSLIFE

SMS Lifesciences India Share Price

₹1,203.60 +23.6 (2%)

21 Dec, 2024 18:41

SIP TrendupStart SIP in SMSLIFE

Start SIP

Performance

  • Low
  • ₹1,199
  • High
  • ₹1,204
  • 52 Week Low
  • ₹487
  • 52 Week High
  • ₹1,750
  • Open Price₹0
  • Previous Close₹1,180
  • Volume1,261

Investment Returns

  • Over 1 Month + 20.32%
  • Over 3 Month -18.95%
  • Over 6 Month + 47.71%
  • Over 1 Year + 139.52%
SIP Lightning

Smart Investing Starts Here Start SIP with SMS Lifesciences India for Steady Growth!

Invest Now

SMS Lifesciences India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.6
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 364
  • P/B Ratio
  • 1.9
  • Average True Range
  • 36.16
  • EPS
  • 72.37
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -26.84
  • RSI
  • 51.33
  • MFI
  • 45.18

SMS Lifesciences India Financials

SMS Lifesciences India Technicals

EMA & SMA

Current Price
₹1,203.60
+ 23.6 (2%)
pointer
  • stock-down_img
  • Bullish Moving Average 12
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹1,183.52
  • 50 Day
  • ₹1,234.48
  • 100 Day
  • ₹1,214.61
  • 200 Day
  • ₹1,077.56

Resistance and Support

1202.07 Pivot Speed
  • R3 1,209.73
  • R2 1,206.67
  • R1 1,205.13
  • S1 1,200.53
  • S2 1,197.47
  • S3 1,195.93

What's your outlook on SMS Lifesciences India?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sms Lifesciences India has an operating revenue of Rs. 333.05 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 15% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 77 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

SMS Lifesciences India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-09 Quarterly Results & A.G.M.
2024-05-27 Audited Results & Dividend
2024-02-10 Quarterly Results & Others
2023-11-11 Quarterly Results

SMS Lifesciences India F&O

SMS Lifesciences India Shareholding Pattern

71.41%
0.02%
25.56%
3.01%

About SMS Lifesciences India

  • NSE Symbol
  • SMSLIFE
  • BSE Symbol
  • 540679
  • Managing Director
  • Mr. TVVSN Murthy
  • ISIN
  • INE320X01016

Similar Stocks to SMS Lifesciences India

SMS Lifesciences India FAQs

SMS Lifesciences India share price is ₹1,203 As on 21 December, 2024 | 18:27

The Market Cap of SMS Lifesciences India is ₹363.9 Cr As on 21 December, 2024 | 18:27

The P/E ratio of SMS Lifesciences India is 16.6 As on 21 December, 2024 | 18:27

The PB ratio of SMS Lifesciences India is 1.9 As on 21 December, 2024 | 18:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23